Psychedelic Medicine: The Next Frontier in Mental Health

Dr. Michael Verbora, MBA MD (Field Trip Medical Director, Toronto) and Dr. Ben Medrano, MD (Field Trip Medical Director, New York) will discuss the paper, present the researched-based evidence of the efficacy of psychedelic therapies, and outline the ongoing clinical work that Field Trip Health is facilitating, using ketamine-assisted therapy to treat treatment-resistant mental health conditions with lasting success. This session will deliver useful & thought-provoking information catered to care providers who wish to learn more about the resurgence of psychedelic medicine.

This webinar will:

• Educate and raise awareness regarding the current options in ketamine-assisted psychotherapy
• Destigmatize the use of psychedelic drugs to treat treatment-resistant mental health conditions
• Create an open forum for the comprehensive white paper report that Field Trip Health has published

This program does not qualify for NAADAC credit.

Speakers

Dr. Michael Verbora
Medical Director,
Field Trip Health
Toronto, Ontario

Dr. Michael Verbora earned an MBA from the Odette School of Business in 2009 and an M.D. from Schulich School of Medicine at Western University in 2013 before entering Family Practice residency at the University of Toronto. He has worked as a leading physician in several clinics and is passionate about furthering knowledge on inner healing intelligence.

Dr. Ben Medrano
Medical Director,
Field Trip Health
New York, New York

Dr. Ben Medrano is a board-certified psychiatrist who completed his undergraduate education at Naropa University and the University of Colorado at Denver. He attended medical school at the University of Colorado School of Medicine, followed by a residency at Mount Sinai Beth Israel in New York City. His clinical practice is influenced by a lifelong interest in eastern psychology and complementary alternative medicine. These interests are further enhanced by his current fellowship at the Integrative Psychiatry Institute sponsored by the University of Colorado School of Medicine.